Amado Zurita-Saavedra

14PUBLICATIONS
99CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 15, 2026
Cardiometabolic health's influence on the efficacy of pre-operative hormone therapy for men with localized high-risk prostate cancer.

|Oct 14, 2026
Talazoparib plus enzalutamide in high-volume metastatic hormone-naive prostate cancer: a randomized phase 2 trial.

|Mar 03, 2026
Influence of body composition on the efficacy of nivolumab plus ipilimumab for metastatic clear cell renal cell carcinoma.

Kabir Grewal, Maria Julia Moura Nascimento Santos, Pankaj Kumar Chauhan

|Feb 24, 2025
Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy.

Yuehui Zhao, Naveen Ramesh, Ping Xu

|Jan 10, 2025
Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial.

Pavlos Msaouel, Kai Yu, Ying Yuan

|Dec 10, 2024
Cells in the Polyaneuploid Cancer Cell State Are Prometastatic.

Mikaela M Mallin, Louis T A Rolle, Michael J Schmidt

Pageof 3

Frequent Collaborators

5 joint publications

Andrew W Hahn

5 joint publications

Ana M Aparicio

4 joint publications

Christopher J Logothetis

4 joint publications

Pavlos Msaouel